Paper36915143
The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.
Yarandi F and 4 others. Eur J Med Res, 2023. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer. Papers, record 36915143. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36915143
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Endometrioid | Major topic |
| Endometrial Neoplasms | Major topic |
| Female | |
| Humans | |
| Retrospective Studies | |
| Neoplasm Recurrence, Local | |
| Iran | |
| Prognosis | |
| Neoplasm Staging | |
| Neoplasm Invasiveness |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28061006 | Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. | Cancer | 2017 | https://conductscience.org/library/papers/28061006 | PubMed |
| 2 | 36254127 | Sentinel lymph node mapping in endometrial cancer to reduce surgical morbidity: always, sometimes, or never. | Prz Menopauzalny | 2022 | https://conductscience.org/library/papers/36254127 | PubMed |
| 3 | 33217679 | Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications. | Eur J Cancer | 2021 | https://conductscience.org/library/papers/33217679 | PubMed |
| 4 | 30550486 | Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade). | Int J Gynecol Pathol | 2019 | https://conductscience.org/library/papers/30550486 | PubMed |
| 5 | 14984936 | A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. | Gynecol Oncol | 2004 | https://conductscience.org/library/papers/14984936 | PubMed |
| 6 | 26746654 | Survival advantage of lymphadenectomy in endometrial cancer. | J Cancer Res Clin Oncol | 2016 | https://conductscience.org/library/papers/26746654 | PubMed |
| 7 | 23600915 | Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer. | Aust N Z J Obstet Gynaecol | 2013 | https://conductscience.org/library/papers/23600915 | PubMed |
| 8 | 31948730 | Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy? | Gynecol Oncol | 2020 | https://conductscience.org/library/papers/31948730 | PubMed |
| 9 | 28067948 | Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study. | Cancer | 2017 | https://conductscience.org/library/papers/28067948 | PubMed |
| 10 | 32749941 | Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy. | J Clin Oncol | 2020 | https://conductscience.org/library/papers/32749941 | PubMed |
| 11 | 33470061 | Substantial lymph-vascular space invasion (LVSI) as predictor of distant relapse and poor prognosis in low-risk early-stage endometrial cancer. | J Gynecol Oncol | 2021 | https://conductscience.org/library/papers/33470061 | PubMed |
| 12 | 24809776 | A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24809776 | PubMed |
| 13 | 26172027 | A clinically applicable molecular-based classification for endometrial cancers. | Br J Cancer | 2015 | https://conductscience.org/library/papers/26172027 | PubMed |
| 14 | 31912681 | Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center. | J Gynecol Oncol | 2020 | https://conductscience.org/library/papers/31912681 | PubMed |
| 15 | 19070889 | Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. | Lancet | 2009 | https://conductscience.org/library/papers/19070889 | PubMed |
| 16 | 10871473 | Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? | Am J Obstet Gynecol | 2000 | https://conductscience.org/library/papers/10871473 | PubMed |
| 17 | 12151144 | Postoperative neuropathies after major pelvic surgery. | Obstet Gynecol | 2002 | https://conductscience.org/library/papers/12151144 | PubMed |
| 18 | 26067863 | Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer. | Int J Gynecol Cancer | 2015 | https://conductscience.org/library/papers/26067863 | PubMed |
| 19 | 31373248 | Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer - a Swedish Gynecologic Cancer Group (SweGCG) study. | Acta Oncol | 2019 | https://conductscience.org/library/papers/31373248 | PubMed |
| 20 | 20188410 | Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. | Lancet | 2010 | https://conductscience.org/library/papers/20188410 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737538 | AKR1B1 and AKR1B10 as Potential Prognostic Biomarkers of Endometrial Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737538 | PubMed |
| 42246563 | Effect of the new FIGO 2023 staging system on stage distribution and adjuvant therapies in endometrial cancer: A retrospective cohort study. | Turk J Obstet Gynecol | 2026 | https://conductscience.org/library/papers/42246563 | PubMed |
| 41326618 | Ultrasound based radiomics nomogram combined with clinical parameters to predict lymphovascular space invasion in endometrioid adenocarcinoma. | Sci Rep | 2025 | https://conductscience.org/library/papers/41326618 | PubMed |
| 41300972 | Association Between MMR Status and Prognostic Pathological Factors in Endometrioid Endometrial Cancer-A Single-Center Retrospective Study. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41300972 | PubMed |
| 41300969 | Molecular Prognosticators Guiding Fertility-Sparing Surgery in Early-Stage Endometrial Cancer: A Comprehensive Review. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41300969 | PubMed |
| 41153317 | Epidemiological and Histopathological Characterization of Endometrial Carcinoma: A Retrospective Cohort from Romania. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/41153317 | PubMed |
| 41010739 | The Impact of Lymphovascular Space Invasion on Recurrence and Survival in FIGO Stage I Node-Negative Endometrioid Endometrial Cancer. | J Clin Med | 2025 | https://conductscience.org/library/papers/41010739 | PubMed |
| 41008861 | Comparative Prognostic Evaluation of the Revised International Federation of Gynecology and Obstetrics 2023 and 2009 Staging Systems in Early Endometrial Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41008861 | PubMed |
| 40304351 | Analysis of the Correlation between MRI Imaging Signs and Lymphovascular Space Invasion in Endometrial Cancer | Curr Med Imaging | 2025 | https://conductscience.org/library/papers/40304351 | PubMed |
| 39114806 | Endometrial cancer treatment and outcomes in Argentina: ECHOS-A real-world study. | Gynecol Oncol Rep | 2024 | https://conductscience.org/library/papers/39114806 | PubMed |
| 39080611 | Prognostic significance of lymphovascular space invasion in early-stage low-grade endometrioid endometrial cancer: a fifteen-year retrospective Chinese cohort study. | World J Surg Oncol | 2024 | https://conductscience.org/library/papers/39080611 | PubMed |
| 38273843 | Evaluation of prognostic significance of lymphovascular space invasion in early stage endometrial cancer: a systematic review and meta-analysis. | Front Oncol | 2023 | https://conductscience.org/library/papers/38273843 | PubMed |
| 38024019 | Endometrial Carcinoma: A Comprehensive Analysis of Clinical Parameters, Treatment Modalities, and Prognostic Outcomes at a Tertiary Oncology Center in the UAE. | Cureus | 2023 | https://conductscience.org/library/papers/38024019 | PubMed |
| 37834206 | Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834206 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NR4A1 | 3164 | PubTator's text mining | https://conductscience.org/library/genes/3164 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36915143
GET https://conductscience.org/api/papers/v1/36915143/references?page=2